A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

A new study shows that targeting key epigenetic proteins may permanently switch off cancer genes. Scientists at Monash University, working with Harvard University, report they have found a way to ...

Artificial intelligence is stepping into the fight against cancer — and, according to Fox News senior medical analyst Dr. Marc Siegel, it could be a game-changer. On the Monday episode of "Fox & ...

Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal of Internal Medicine, researchers at Karolinska Institutet present ...

Mayo Clinic researchers say they have discovered that ovarian cancer cells can quickly activate a survival response after treatment with PARP inhibitors.

A quiet problem has followed cancer immunotherapy for years. The immune system can be taught to fight, then it fades. T cells ...

If you have metastatic breast cancer that’s hormone receptor-positive (HR+) and HER2-negative, your treatment plan looks very different from how it might have decades ago. Instead of relying on ...

Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves endoscopy, imaging, laparoscopy, and molecular testing for markers like HER2 ...